Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
Clinical trial NCT03443973 · TERMINATED
Trial details
- NCT number
- NCT03443973
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2022-09-23
- Enrollment
- 975
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.